Capital Public Radio, Inc.7055 Folsom BoulevardSacramento,
(916) 278-8900(877) 480-5900
90.9 FM Sacramento
90.5 FM Tahoe/Reno
91.3 FM Stockton/Modesto
88.1 FM Quincy
88.9 FM Sacramento
91.7 FM Groveland/Sonora
88.7 FM Sutter/Yuba City
KQNC 88.1 in Quincy is currently off the air. We're working to restore service as soon as possible. Thank you for your patience.
Science, technology, environment and health news and discussion with host Ira Flatow.
Friday 11 a.m. – 1 p.m and 9 p.m. – 11 p.mon News Station
A 39-year-old woman, the first participant enrolled in the Phase 1 clinical trial VRC 207, received a dose of the investigational NIAID/GSK Ebola vaccine at the NIH Clinical Center in Bethesda, Maryland, on September 2, 2014.
Photo courtesy of NIAID
Ebola Vaccines Fast-Tracked As Outbreak Slows
Could This 3-D Printer Print Itself?
Scientists Sniff Smelly Comet
Countering Memory Loss With Cocoa Compounds
Creature Double Feature
Doctors ‘Unwrap’ a 3,000-Year-Old Mummy
A Haunted House Turned Scientists’ Lab
Behind the Monster Music: Why Some Tunes Scare Us